Everus Construction Group, Inc.
ECG NYSE Operative Builders Financials FY2022βFY2025
What Everus Construction Group, Inc. does
No business description yet.
- Legal name
- Everus Construction Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0002015845-26-000010
0002015845
Revenue and margins
Everus Construction Group, Inc. had $3.7B of revenue in fiscal 2025, up 31.5% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew 17.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $90.0M in fiscal 2025, 2.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Everus Construction Group, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Everus Construction Group, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $2.1M | $1.6M | $86.0M | $171M |
| Debt incl. finance leases | β | $169M | $296M | $282M |
| Net debt / EBITDA | β | 0.8x | 1.0x | 0.4x |
| Debt / equity | β | 0.4x | 0.7x | 0.4x |
| Interest coverage | 25.9x | 11.2x | 13.5x | 12.3x |
| Current ratio | β | 1.9x | 1.8x | 1.8x |
| Quick ratio | β | 1.7x | 1.7x | 1.7x |
| Total assets | β | $1.1B | $1.3B | $1.7B |
| Total liabilities | β | $604M | $866M | $1.1B |
| Shareholders' equity | $382M | $449M | $423M | $630M |
| Net debt (β = net cash) | β | $167M | $210M | $111M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 5 | 4 / 9 | 5 / 9 |
| Accruals ratio | β | β3.2% | β1.7% | 3.0% |
| Altman Z'' | β | 5.06 | 4.28 | 4.67 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.7B | $2.9B | $2.8B | $3.7B |
| Gross profit | $276M | $322M | $339M | $454M |
| Operating income | $165M | $191M | $190M | $265M |
| Interest expense | $6.4M | $17.0M | $14.0M | $21.5M |
| Pretax income | $160M | $178M | $181M | $258M |
| Income tax | $40.8M | $45.3M | $49.5M | $72.3M |
| Net income | $125M | $137M | $143M | $202M |
| Diluted EPS | $2.45 | $2.69 | $2.81 | $3.95 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||
| Cash from operations | β$25.5M | $171M | $163M | $157M |
| Capital expenditure | $35.8M | $35.6M | $48.3M | $66.8M |
| Free cash flow | β$61.3M | $136M | $115M | $90.0M |
| Depreciation and amortization | $19.2M | $21.1M | $23.4M | $28.7M |
| Stock-based compensation | $1.1M | $0.8M | $1.6M | $6.3M |
| Balance sheet | ||||
| Cash and short-term investments | $2.1M | $1.6M | $86.0M | $171M |
| Total debt | β | $169M | $296M | $282M |
| Current assets | β | $729M | $917M | $1.3B |
| Current liabilities | β | $394M | $513M | $736M |
| Inventory | β | $42.7M | $43.8M | $45.3M |
| Property and equipment, net | β | $116M | $134M | $168M |
| Goodwill | β | $143M | $143M | $143M |
| Intangible assets | β | $2.0M | $0.1M | $0.0M |
| Total assets | β | $1.1B | $1.3B | $1.7B |
| Total liabilities | β | $604M | $866M | $1.1B |
| Shareholders' equity | $382M | $449M | $423M | $630M |
| Margins | ||||
| Gross margin | 10.2% | 11.3% | 11.9% | 12.1% |
| Operating margin | 6.1% | 6.7% | 6.7% | 7.1% |
| EBITDA margin | 6.8% | 7.4% | 7.5% | 7.8% |
| Net margin | 4.6% | 4.8% | 5.0% | 5.4% |
| FCF margin | β2.3% | 4.8% | 4.0% | 2.4% |
| Returns | ||||
| Return on capital | β | 23.1% | 21.8% | 25.7% |
| Return on capital employed | β | 28.9% | 24.5% | 26.7% |
| Return on equity | 32.6% | 33.0% | 32.9% | 38.3% |
| Return on assets | β | 13.0% | 12.3% | 13.4% |
| Return on tangible equity | 32.6% | 45.2% | 51.4% | 41.5% |
| Growth | ||||
| Revenue growth | β | 5.7% | β0.2% | 31.5% |
| Net income growth | β | 10.0% | 4.5% | 40.7% |
| EPS growth | β | 9.8% | 4.5% | 40.6% |
| FCF growth | β | β | β15.2% | β21.8% |
| Share count change | β | 0.0% | 0.2% | 0.1% |
| Financial health | ||||
| Net debt / EBITDA | β | 0.8x | 1.0x | 0.4x |
| Debt / equity | β | 0.4x | 0.7x | 0.4x |
| Interest coverage | 25.9x | 11.2x | 13.5x | 12.3x |
| Current ratio | β | 1.9x | 1.8x | 1.8x |
| Quick ratio | β | 1.7x | 1.7x | 1.7x |
| Capital allocation | ||||
| Capex / revenue | 1.3% | 1.2% | 1.7% | 1.8% |
| Stock comp / revenue | 0.0% | 0.0% | 0.1% | 0.2% |
| Quality scores | ||||
| Piotroski F-score | β | β | 4.0 | 5.0 |
| Altman Z'' | β | 5.1 | 4.3 | 4.7 |
| Accruals ratio | β | β3.2% | β1.7% | 3.0% |
Source: SEC EDGAR XBRL filings (CIK 0002015845). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.